|
As filed with the Securities and Exchange Commission on September 4, 2020
Registration No. 333-
|
|
Delaware
|
74-1408526
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
1025 Willa Springs Drive
Winter Springs, FL 32708
|
|
|
(Address of principal executive offices) (Zip Code)
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☒
|
|
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☒
|
|
|
Emerging growth company
|
☐
|
|
Title of securities
to be registered
|
Amount to be
registered(1)
|
Proposed maximum
offering
price per share
|
Proposed maximum
aggregate
offering price
|
Amount of
registration fee
|
|
Common Stock, $0.0001 par value per share
|
1,000,000(2)
|
$21.21(3)
|
$21,210,000.00
|
$2,753.06
|
| (1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (“Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock that become issuable in respect of the
securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of
the outstanding shares of the Registrant’s Common Stock.
|
| (2) |
Represents additional shares of Registrant’s Common Stock reserved for issuance under its Amended and Restated 2014 Equity Incentive Plan as of the date of this Registration Statement.
|
| (3) |
Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee based on the average of the high and low prices of the Registrant’s Common Stock as reported on the
Nasdaq Capital Market on August 31, 2020.
|
| Item 3. |
Incorporation of Documents by Reference.
|
| (a) |
the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as filed on March 6, 2020;
|
| (b) |
all other reports filed by the Registrant pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the annual report referred to in (a) above (in each case, except for the information furnished
under Items 2.02 or 7.01 in any current report on Form 8-K); and
|
| (c) |
the description of our common stock contained in our Registration Statement on Form 8-A (File No. 001-36534) filed with SEC on July 10, 2014, including any amendment or report filed for the purpose of updating such description.
|
| Item 4. |
Description of Securities.
|
| Item 5. |
Interests of Named Experts and Counsel.
|
| Item 6. |
Indemnification of Directors and Officers.
|
| Item 7. |
Exemption from Registration Claimed.
|
| Item 8. |
Exhibits
|
|
|
|
|
|
|
Incorporated by Reference
|
||||
|
Exhibit
No.
|
Exhibit Title
|
|
Herewith
|
|
Form
|
|
File No.
|
|
Date Filed
|
|
Amended and Restated Certificate of Incorporation
|
|
|
|
DEF 14C
|
|
001-36534
|
|
October 9, 2015
|
|
|
Third Amended and Restated Bylaws of the Registrant
|
|
|
|
8-K
|
|
001-36534
|
|
September 19, 2018
|
|
|
Specimen common stock certificate
|
|
|
S-1A
|
333-196875
|
July 9, 2014
|
||||
|
Opinion of K&L Gates LLP regarding legality of securities being registered
|
|
X
|
|
|
|
|
|
|
|
|
Consent of RSM US LLP, Independent Registered Public Accounting Firm
|
|
X
|
|
|
|
|
|
|
|
|
Consent of K&L Gates LLP (included in Exhibit 5.1)
|
|
X
|
|
|
|
|
|
|
|
|
Power of Attorney (included on signature page)
|
|
X
|
|
|
|
|
|
|
|
|
Amended and Restated Iradimed Corporation 2014 Equity Incentive Plan and the forms of award agreements thereunder
|
|
|
10-Q
|
001-36534
|
August 6, 2020
|
||||
| Item 9. |
Undertakings.
|
|
|
IRADIMED CORPORATION
|
|
|
|
|
|
|
|
By:
|
/s/ Roger Susi
|
|
|
|
|
|
|
Name:
|
Roger Susi
|
|
|
Title:
|
President, Chief Executive Officer and Chairman of the
Board of Directors
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
||
|
/s/ Roger Susi
|
|
President, Chief Executive Officer and Chairman of the Board of Directors
|
|
September 4, 2020
|
|
Roger Susi
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|||
|
/s/ Chris Scott
|
|
Chief Financial Officer and Corporate Secretary
|
|
September 4, 2020
|
|
Chris Scott
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|||
|
/s/ Monty Allen
|
|
Director
|
|
September 4, 2020
|
|
Monty Allen
|
|
|
|
|
|
|
|
|||
|
/s/ Anthony Vuoto
|
|
Director
|
|
September 4, 2020
|
|
Anthony Vuoto
|
|
|
|
|
|
|
|
|||
|
/s/ James Hawkins
|
|
Director
|
|
September 4, 2020
|
|
James Hawkins
|
|
|
|
|